Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IWWM-11 2022 | Long non-coding RNA expression in IgM-MGUS and Waldenström’s macroglobulinemia

Jonas Paludo • 28 Oct 2022
IWWM-11 2022
Lymphoma Non-Hodgkin Lymphoma Rare Diseases Waldenström’s Macroglobulinemia

Jonas Paludo, MD, Mayo Clinic, Rochester, MN, shares some insights into the importance of long non-coding RNA expression in Waldenström’s macroglobulinemia (WM), and how the expression of these RNAs may play a role in disease progression. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Karyopharm and Biofourmis – both research funding to my institution

More from Jonas Paludo

2:36
Managing CAR-T therapy-related AEs & treatment options for patients who progress after CAR-T therapy
Jonas Paludo • 28 Oct 2022
0:57
The importance of studying RNA expression in rare diseases such as WM
Jonas Paludo • 28 Oct 2022
Waldenström’s macroglobulinemia highlights from ASH 2018
Jonas Paludo • 4 Dec 2018
Association between depth of response and survival in Waldenström’s
Jonas Paludo • 6 Dec 2018

Related Videos

3:32
Improving CAR-T therapy for ALL & lymphoma: allogeneic products & reducing CRS/ICANS
Sridhar Chaganti • 16 Apr 2024
2:11
The role of CAR-T therapy for lymphoma in 2024: expert session highlights
Sridhar Chaganti • 16 Apr 2024
3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
1:32
Promising novel immunotherapeutic approaches in lymphoma
Gloria Iacoboni • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals